Showing results (381-390 of 621) with videos related to

Sort By:
Pageof 63
American Journal of Clinical Pathology|May 1, 1992
Erythrocyte antioxidant activity, serum ceruloplasmin, and trace element levels in subjects with alcoholic liver diseaseG Gerli, G F Locatelli, R Mongiat, et al.
American Journal of Medical Genetics. Supplement|January 1, 1990
Erythrocyte antioxidant system in Down syndromeG Gerli, L Zenoni, G F Locatelli, et al.
European Journal of Pediatrics|January 7, 1999
Recommendations on the use of colony-stimulating factors in children: conclusions of a European panelG Schaison, O B Eden, G Henze, et al.
British Journal of Haematology|September 21, 2001
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donorC L Balduini, F Frassoni, P Noris, et al.
British Journal of Haematology|April 1, 1995
High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre studyC Uderzo, R Rondelli, G Dini, et al.
Bone Marrow Transplantation|January 1, 1991
Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donorF Locatelli, M Bongiorno, M Zecca, et al.
Clinical Nephrology|August 1, 1992
Chronic dialysis in patients with systemic amyloidosis: the experience in northern ItalyG Moroni, G Banfi, A Montoli, et al.
Vox Sanguinis|January 25, 2005
Association of ABO gene mutations resulting in a rare B subgroupN Sousa, J M Anicchino-Bizzacchi, E M Leite, et al.
British Journal of Haematology|September 1, 1999
Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantationC L Balduini, P Noris, G Giorgiani, et al.
Cancer Genetics and Cytogenetics|November 14, 1997
Ph-positive CML in blastic phase with monosomy 7 in a Down syndrome patient. Monitoring by interphase cytogenetics and demonstration of maternal allelic lossL Seghezzi, C Dellavecchia, E Maserati, et al.
Pageof 63